Based on these insights, we aimed to assess the impact of combined lipid and inflammation markers including ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, IL-6, HOMA-IR and CRP on PCOS development across three different BMI groups. The gene discussed is IL6; the disease is polycystic ovary syndrome.